These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy]. Justesen US, Pedersen C. Ugeskr Laeger; 2000 Aug 28; 162(35):4664-5. PubMed ID: 10986895 [Abstract] [Full Text] [Related]
24. d4T plus ddI: warning for pregnant women. AIDS Treat News; 2001 Jan 12; (358):8. PubMed ID: 12173560 [Abstract] [Full Text] [Related]
25. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial). Feeney ER, Chazallon C, O'Brien N, Meiffrédy V, Goodall RL, Aboulker JP, Cooper DA, Yeni P, Mallon PW, INITIO Trial International Co-ordinating Committee. HIV Med; 2011 Nov 12; 12(10):602-9. PubMed ID: 21599820 [Abstract] [Full Text] [Related]
28. A case of lactic acidosis caused by stavudine in an AIDS patient. Cho BC, Han SH, Choi SH, Choi JY, Chang KH, Song YG, Kim JM. Korean J Intern Med; 2004 Mar 12; 19(1):66-9. PubMed ID: 15053048 [Abstract] [Full Text] [Related]
29. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore. Hwang SW, Leo YS. Singapore Med J; 2001 Jun 12; 42(6):247-51. PubMed ID: 11547960 [Abstract] [Full Text] [Related]
37. Double "d" drug danger. Moyle G. AIDS Read; 2003 Jan 12; 13(1):15-6, 23-4. PubMed ID: 12569891 [No Abstract] [Full Text] [Related]
38. Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatment. Gérard Y, Viget N, Yazdanpanah Y, Ajana F, de La Tribonnière X, Bocket L, Deuffic-Burban S, Dos Santos A, Ballester L, Mouton Y. Therapie; 2003 Jan 12; 58(2):153-8. PubMed ID: 12942856 [Abstract] [Full Text] [Related]